Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Primary treatment for advanced ovarian cancer is with surgery and chemotherapy. The completeness of the initial surgical resection correlates to the overall survival.
Intuitively it has been thought that, for recurrent ovarian cancer, further surgery would be beneficial.
In this clinical trial treatment for 485 patients was randomly selected, 240 for repeat surgery before chemotherapy and 245, chemotherapy alone.
No increase in survival was noted following surgery. Patients’ quality of life deteriorated in the immediate post-operative period
No comments:
Post a Comment